Author:
Bernhaus Astrid,Ozsvar-Kozma Maria,Saiko Philipp,Jaschke Margit,Lackner Andreas,Grusch Michael,Horvath Zsuzsanna,Madlener Sibylle,Krupitza Georg,Handler Norbert,Erker Thomas,Jaeger Walter,Fritzer-Szekeres Monika,Szekeres Thomas
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference40 articles.
1. Blackstock AW, Cox AD, Tepper JE (1996) Treatment of pancreatic cancer: current limitations, future possibilities. Oncology (Williston Park) 10:301–307, discussion: 308–323, 1996
2. Raimondi S, Maisonneuve P, Löhr JM, Lowenfels AB (2007) Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol Biomarkers Prev 16:1894–1897 doi: 10.1158/1055-9965.EPI-07-0341
3. Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D et al (2007) Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. Surg Res 138:163–169 doi: 10.1016/j.jss.2006.05.037
4. DiMagno EP, Reber HA, Tempero MA (1999) AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 117:1464–1484 doi: 10.1016/S0016-5085(99)70298-2
5. Norell SE, Ahlbom A, Erwald R, Jacobson G, Lindberg-Navier I, Olin R et al (1986) Diet and pancreatic cancer: a case-control study. Am J Epidemiol 124:894–902
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献